-318.56
(-0.39%)
-155.05
(-0.61%)
-497.09
(-2.64%)
GET IN TOUCH
SEBI presents Samajh Se Investing Simple:
RISK DISCLOSURES ON DERIVATIVES
|
Corporate News 14-Nov-2026 22:39 Parmax Pharma confirms no deviation in utilization of Rs 19.28 crore funds Parmax Pharma Limited informed the BSE that it has confirmed no deviation or variation in the utilization of Rs 19,28,19,682 raised through the issuance of equity shares and warrants on a preferential basis, as per Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended September 30, 2026. |
INDIAN INDICES
81,592.45 -318.56 (-0.39%)
25,144.30 -155.05 (-0.61%)
GLOBAL INDICES
NA
23,625.14 -383.42(-1.60%)

